| Synonyms: | |
| Status: | Phase 2 |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| UNII: | S3UN2146K9 |
| InChI Key | PNTNBIHOAPJYDB-UHFFFAOYSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C17H16N2O4 |
| Molecular Weight | 312.33 |
| AlogP | 2.1 |
| Hydrogen Bond Acceptor | 4.0 |
| Hydrogen Bond Donor | 2.0 |
| Number of Rotational Bond | 5.0 |
| Polar Surface Area | 84.33 |
| Molecular species | NEUTRAL |
| Aromatic Rings | 3.0 |
| Heavy Atoms | 23.0 |
| Action | Mechanism of Action | Reference |
|---|---|---|
| AGONIST | Melatonin receptor agonist | PubMed |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Alzheimer Disease | 2 | D000544 | ClinicalTrials |
| Sleep Initiation and Maintenance Disorders | 2 | D007319 | ClinicalTrials |
| Resources | Reference |
|---|---|
| CAS NUMBER | 946846-83-9 |
| ChEMBL | CHEMBL4297523 |
| DrugBank | DB12288 |
| EPA CompTox | DTXSID90241566 |
| FDA SRS | S3UN2146K9 |
| PubChem | 24815904 |
| SureChEMBL | SCHEMBL8235551 |